Právní předpis byl sestaven k datu 14.01.2025.
Zobrazené znění právního předpisu je účinné od 08.03.2018.
Nařízení vlády, kterým se mění nařízení vlády č. 463/2013 Sb., o seznamech návykových látek, ve znění pozdějších předpisů
30/2018 Sb.
30
XXXXXXXX XXXXX
xx xxx 31. xxxxx 2018,
kterým xx xxxx xxxxxxxx xxxxx č. 463/2013 Sb., x xxxxxxxxx návykových látek, xx xxxxx pozdějších xxxxxxxx
Xxxxx xxxxxxxx xxxxx §44c xxxx. 1 xxxxxx č. 167/1998 Xx., o xxxxxxxxxx xxxxxxx x o xxxxx xxxxxxxxx dalších xxxxxx, xx xxxxx xxxxxx x. 273/2013 Xx.:
Xx. X
1. X §2 xx xxxxxxxxx xxxx označuje xxxx xxxxxxxx 1 a xxxxxxxx se xxxxxxxx 2, xxxxx xxxxxx xxxxxxxx pod čarou x. 3 zní:
"(2) Xxxx nařízení xxxxxxxxxxx xxxxxxxxx xxxxxxxx Xxxxxxxx xxxx xxxxxxxx se xxxxxxxxxx xxxxx3).
3) Xxxxxxx xxxxxxxxxx Rady 2004/757/SVV xx xxx 25. xxxxx 2004, kterým xx xxxxxxx xxxxxxxxx xxxxxxxxxx týkající xx xxxxx skutkových xxxxxxx xxxxxxxxx xxxx a xxxxxx x xxxxxxx xxxxxxxxxxxx xxxxxxx s xxxxxxx.
Xxxxxxxx Evropského xxxxxxxxxx x Xxxx (XX) 2017/2103 xx xxx 15. xxxxxxxxx 2017, xxxxxx se mění xxxxxxx xxxxxxxxxx Xxxx 2004/757/XXX x xxxxx xxxxxxxx xx xxxxxxxx xxxxx nové xxxxxxxxxxxxx xxxxx x zrušuje xxxxxxxxxx Xxxx 2005/387/SVV.".
2. Xxxxxxx x. 4 xxx:
"Xxxxxxx x. 4 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 4 psychotropních xxxxx
|
Xxxxxxxxxxx nechráněný xxxxx (XXX) v českém xxxxxx / xxxxxx xxxxx |
Xxxxx xxxxxxxxxxx nechráněný xxxxx nebo xxxxx xxxxxx název |
Chemický xxxxx xxxxx IUPAC |
Poznámka |
|
AB-CHMINACA |
N-[(1S)-1-(aminokarbonyl)-2-methylpropyl]-1(cyklohexylmethyl)-1H-indazol-3-karboxamid |
||
|
AB-FUBINACA |
N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorbenzyl)-1H-indazol-3-karboxamid |
||
|
AB-PINACA |
N-[(1S)-1-(aminokarbonyl)-2-methylpropyl]-1-pentyl-1H-indazol-3-karboxamid |
||
|
4-Acetoxy-N-methyl-N-ethyltryptamin |
4-AcO-MET |
{3-[2-(ethylmethylamino)ethyl]-1H-indol-4-yl}acetát |
|
|
o-Acetylpsilocin |
4-AcO-DMT |
{3-[2-(dimethylamino)ethyl]-1H-indol-4-yl}acetát |
Psilacetin |
|
ADB-CHMINACA |
N-[1-(aminokarbonyl)-2,2-dimethylpropyl]-1-(cyklohexylmethyl)-1H-indazol-3-karboxamid |
||
|
ADB-FUBINACA |
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-[(4-fluorfenyl)methyl]indazol-3-karboxamid |
||
|
ADB-PINACA |
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazol-3-karboxamid |
||
|
AH-7921 |
3,4-dichlor-N-{[1-(dimethylamino)cyklohexyl]methyl}benzamid |
||
|
AL-LAD |
(6aR,9R)-7-allyl-N,N-diethyl-6,6a,8,9-tetrahydro-4H-indol[4,3-fg]chinolin-9-karboxamid |
6-allyl-6-nor-LSD |
|
|
AM-2201 |
[1-(5-fluorpentyl)-1H-indol-3-yl](naftalen-1-yl)methanon |
||
|
AMB-FUBINACA |
FUB-AMB |
Methyl 2-({1-[(4-fluorfenyl)methyl]-1H-indazol-3-karbonyl}amino)-3-methylbutanoát |
MMB-FUBINACA |
|
AMB-CHMICA |
Methyl (2X)-2-{[1-(xxxxxxxxxxxxxxxx)xxxxx-3-xxxxxxxx]xxxxx}-3-xxxxxxxxxxxxxx |
||
|
5-Xxxxxxxxxxxxxxxx |
5-XXX |
5-(2-xxxxxxxxxxx)xxxxx |
|
|
XXXXX |
XXX-001, 2NE1 |
N-(adamantan-1-yl)-1-pentyl-1H-indol-3-karboxamid |
|
|
APINACA |
N-(adamantan-1-yl)-1-pentyl-1H-indazol-3-karboxamid |
AKB48 |
|
|
bk-PMA |
2-amino-1-(4-methoxyfenyl)propan-1-on |
||
|
Methedron |
bk-PMMA |
1-(4-methoxyfenyl)-2-(methylamino)propan-1-on |
|
|
2-Brommethkathinon |
2-BMC |
(RS)-1-(2-bromfenyl)-2-(methylamino)propan-1-on |
|
|
3-Brommethkathinon |
3-BMC |
(RS)-1-(3-bromfenyl)-2-(methylamino)propan-1-on |
|
|
4-Brommethkathinon |
4-BMC |
(RS)-1-(4-bromfenyl)-2-(methylamino)propan-1-on |
Brefedron |
|
25B-NBOMe |
2-(4-brom-2,5-dimethoxyfenyl)-N-[(2-methoxyfenyl)methyl]ethanamin |
Cimbi-36 |
|
|
25C-NBOMe |
2-(4-chlor-2,5-dimethoxyfenyl)-N-[(2-methoxyfenyl)methyl]ethanamin |
2C-C-NBOMe |
|
|
25I-NBOH |
2-{[2-(4-jod-2,5-dimethoxyfenyl)ethylamino]methyl}fenol |
2C-I-NBOH; Xxxxx-27 |
|
|
25X-XXXXx |
2-(4-xxx-2,5-xxxxxxxxxxxxxx)-X-[(2-xxxxxxxxxxxx)xxxxxx]xxxxxxxxx |
XXXXx-2X-X |
|
|
Xxxxx-Xxxxxxxxx |
(2X)-1-(4-xxxxxxxx[2,3-x][1]xxxxxxxxxx-8-xx)xxxxxx-2-xxxx |
||
|
Xxxxxxx |
Xx-XXXX |
2-(xxxxxxxxxxx)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxx-1-xx |
X1 |
|
2-Xxxxxxxxxxxxxx |
2-XX |
1-(2-xxxxxxxxxx)xxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxx |
3-XX |
1-(3-xxxxxxxxxx)xxxxxx-2-xxxx |
|
|
4-Xxxxxxxxxxxxxx |
4-XX |
1-(4-xxxxxxxxxx)xxxxxx-2-xxxx |
XXX |
|
2-Xxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxxxxxxx |
4-Xx-xXX |
X-(4-xxxxxxxxxx)-2-xxxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx |
|
|
2X-X |
2-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxx-1-xxxx |
||
|
2-Xxxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
4-Xxxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
x-XXX |
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
Xxxxxxxxx |
|
2-Xxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxxx |
4-Xx-α-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
|
XXXXX-4XX-XXXXXX |
XXX-78 |
1-(4-xxxxxxxxxx)-X-(1-xxxxxx-1-xxxxxxxxxx)xxxxxxx-3-xxxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxxxx |
Xxxxxxxxxxx-X; XX-X |
X-xxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxx]xxxxxxxxxxxxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
2X-X-2 |
[4-(xxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx]xxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
2X-X-7 |
[4-(xxxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx]xxxx |
|
|
XX-47,497 |
2-[(1X,3X)-3-xxxxxxxxxxxxxxxxx]-5-(2-xxxxxxxxxxx-2-xx)xxxxx |
||
|
XXX-13 |
(xxxxxxxx-1-xx)[4-(xxxxxxxxx)xxxxxxxx-1-xx]xxxxxxxx |
XX-13 |
|
|
XXXX |
1,4-xxxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxx |
2-(xxxxxxxxxxx)-2-xxxxx-xxxxxxxxxxxx |
||
|
Xxxxxxxxxxxx-2-xxxxx xxxxxxxx |
X-(2-xxxxxxxxxx)-1-(2-xxxxxxxxxx)xxxxxxxxx-4-xxxx |
||
|
Xxxxxxxxxxxx-4-xxxxx fentanyl |
N-(4-fluorfenyl)-1-(2-fenylethyl)piperidin-4-amin |
||
|
Dibutylon |
Bk-DMBDB |
1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)-1-butanon |
Methylbutylon |
|
Diclazepam |
2-chlorodiazepam |
7-chlor-5-(2-chlorfenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
Ro 5-3448 |
|
Xxxxxxxxxxxxxxxx |
XXX |
X,X-xxxxxxx-X-[2-(xxxxx-3-xx)xxxxx]xxxx |
|
|
5-Xxxxxxxxxxxxxxxxxxxxxxxxxxxx |
5-XXXXX; XXXX |
1-(2,3-xxxxxxxxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
|
Xxxxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
x-Xxxxxx-4-xxxxxxxxxxxxxx |
4,4'-XXXX |
4-xxxxxx-5-(4-xxxxxxxxxxx)-4,5-xxxxxxx-1,3-xxxxxx-2-xxxx |
x4-XXXX |
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
XXXX |
3-(1,2-xxxxxxxxxxxxxx)-6,6,9-xxxxxxxxx-7,8,9,10-xxxxxxxxxx-6X-xxxxx[x]xxxxxxx-1-xx |
|
|
2,3-Xxxxxxxxxxxxxxxxxxx |
2,3-XXXX |
1-(2,3-xxxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
2,4-Xxxxxxxxxxxxxxxxxxx |
2,4-XXXX |
1-(2,4-xxxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3,4-Xxxxxxxxxxxxxxxxxxx |
3,4-XXXX |
1-(3,4-xxxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
Xxxxxxxxxxxxxxxxx |
XXX |
X-[2-(xxxxx-3-xx)xxxxx]-X,X-xxxxxxxxxxxx |
|
|
Xxxxxxxxxxxxx |
XXX |
(2XX)-1-(4-xxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
2,5-Xxxxxxxxx-4-xxxxxxxxxxxxxx |
XXX |
1-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxxxx |
XXXX |
(2XX)-1-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxx |
XXX, DOM |
(2RS)-1-(2,5-dimethoxy-4-methylfenyl)propan-2-amin |
|
|
2,5-Dimethoxy-4-jodamfetamin |
DOI |
1-(4-jod-2,5-dimethoxyfenyl)propan-2-amin |
|
|
5-EAPB |
1-(1-benzofuran-5-yl)-N-ethylpropan-2-amin |
||
|
6-EAPB |
1-(1-benzofuran-6-yl)-N-ethylpropan-2-amin |
||
|
Methkathinon |
Efedron |
(2RS)-1-fenyl-2-(methylamino)propan-1-on |
|
|
Ephylon |
MDEVP; xx-XXXX |
1-(xxxxx[x][1,3]xxxxxx-5-xx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
X-xxxxx-xxxxxxxx |
|
XXX-XXX |
(6xX,9X)-X,X-xxxxxxx-7-xxxxx-4,6,6x,7,8,9-xxxxxxxxxxxxxx-[4,3-xx]xxxxxxxx-9-xxxxxxxxxx |
||
|
Xxxxxxxx |
XXX 3219; Depas |
4-(2-chlorfenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin |
|
|
Ethylfenidát |
(RS)-ethyl-2-fenyl-2-piperidin-2-ylacetát |
||
|
2-Ethylmethkathinon |
2-EMC |
(RS)-2-methylamino-1-(2-ethylfenyl)propan-1-on |
|
|
3-Ethylmethkathinon |
3-EMC |
(RS)-2-methylamino-1-(3-ethylfenyl)propan-1-on |
|
|
4-Ethylmethkathinon |
4-EMC |
(RS)-2-methylamino-1-(4-ethylfenyl)propan-1-on |
|
|
Etryptamin |
3-(2-aminobutyl)indol |
||
|
2-Fluoramfetamin |
2-FA |
1-(2-fluorfenyl)propan-2-amin |
|
|
3-Fluoramfetamin |
3-FA |
1-(3-fluorfenyl)propan-2-amin |
|
|
4-Fluoramfetamin |
4-FA |
1-(4-fluorfenyl)propan-2-amin |
|
|
5F-ADBICA |
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluorpentyl)-1H-indol-3-karboxamid |
||
|
5F-AKB48 |
N-(adamantan-1-yl)-1-(5-fluorpentyl)-1H-indazol-3-karboxamid |
||
|
5F-AMB-PINACA |
5F-AMB |
Methyl-2-({[1-(5-fluorpentyl)-1H-indazol-3-yl]karbonyl}amino)-3-methylbutanoát |
5F-AMP |
|
Fentanyl xxxxxxxxx analog |
Butyrfentanyl |
N-fenyl-N-[1-(2-fenylethyl)-4-piperidinyl]-butanamid |
|
|
3F-Fenmetrazin |
3-FPM; PAL-593 |
2-(3-fluorofenyl)-3-methylmorfolin |
|
|
4F-Fenmetrazin |
4-FPM |
2-(4-fluorofenyl)-3-methylmorfolin |
|
|
4-Fluor-butyrfentanyl |
4F-BF |
N-(4-fluorofenyl)-N-[(1-(2-fenylethyl)-4-piperidinyl)]butanamid |
|
|
2-Fluorethkathinon |
2-FEC |
1-(2-fluorfenyl)-2-(ethylamino)propan-1-on |
|
|
3-Fluorethkathinon |
3-FEC |
1-(3-fluorfenyl)-2-(ethylamino)propan-1-on |
|
|
4-Fluorethkathinon |
4-FEC |
1-(4-fluorfenyl)-2-(ethylamino)propan-1-on |
|
|
2-Fluorfentanyl |
Ortofluorfentanyl |
N-(2-fluorfenyl)-N-[1-(2-fenylethyl)-4-piperidinyl]propanamid |
2-FF, x-XX |
|
3-Xxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
X-(3-xxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx |
3-XX, x-XX |
|
4-Xxxxxxxxxxxxxxxxxxxxx |
4X-xXX |
X-(4-xxxxxxxxxx)-2-xxxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx |
|
|
2-Xxxxxxxxxxxxxxxxxx |
2-XXX |
(XX)-1-(2-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxxxxxx |
3-XXX |
(XX)-1-(3-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
4-Xxxxxxxxxxxxxxxxxx |
4-XXX |
(XX)-1-(4-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
Xxxxxxxxx |
|
4-Xxxxxxxxxxxxxxxxxx |
4X-XXX; 4-FMPH |
Methyl-2-(4-fluorfenyl)-2-(2-piperidyl)acetát |
4F-TMP |
|
5F-PB-22; 5X-XXXXX |
8-xxxxxxxxxx xxxxx xxxxxxxx 1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxxx |
||
|
5X-XXXX-XXXXXX |
5X-XXX |
xxxxxx (S)-2-({[1-(5-fluorpentyl)-1H-indazol-3-yl]karbonyl}amino)-3,3-dimethylbutanoát |
|
|
5FUR-144 |
[1-(5-fluorpentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyklopropyl)methanon |
XLR-11 |
|
|
Furanylfentanyl |
FU-F |
N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]-furan-2-karboxamid |
2-furanoylfentanyl |
|
4-Hydroxy-N-methyl-N-ethyl xxxxxxxxx |
4-XX-XXX |
3-{2-[xxxxx(xxxxxx)xxxxx]xxxxx}-1X-xxxxx-4-xx |
Xxxxxxx; Xxxxxxxxxxx |
|
4-Xxxxxxx-X-xxxxxx-X-xxxxxxxxx xxxxxxxxx |
4-XX-XxXX |
3-{2-[xxxxxx(xxxxxx-2-xx)xxxxx]xxxxx}-1X-xxxxx-4-xx |
Xxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxx |
(2XX)-X-xxxxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
||
|
(xxx)Xxxxxxx-X-xxxxxxxx N-benzyl xxxxxx |
X-(1-xxxxxxxxxxxxxxx-4-xx)-X-(4-xxxxxxxxxx)xxxxxxxxx |
||
|
Xxxxxxxxxxxxxxxxxxxxxxxx |
2X-X |
(4-xxx-2,5-xxxxxxxxxxxxxxxxxxx)xxxx |
|
|
XXX-018 |
(xxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
XXX-073 |
(1-xxxxx-1X-xxxxx-3-xx)(xxxxxxxx-1-xx)xxxxxxxx |
||
|
XXX-081 |
(4-xxxxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
XXX-122 |
(4-xxxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
XXX-200 |
[1-(2-xxxxxxxxxxxxxx)-1X-xxxxx-3-xx](xxxxxxxx-1-xx)xxxxxxxx |
||
|
XXX-210 |
(4-xxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
XXX-250 |
2-(2-xxxxxxxxxxxx)-1-(1-xxxxxx-1X-xxxxx-3-xx)xxxxx-1-xx |
||
|
XXX-398 |
(4-xxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3 -yl)methanon |
||
|
Kathinon |
(2S)-2-amino-1-fenylpropan-1-on |
||
|
(+)-Lysergid |
LSD, LSD-25 |
(+)-8β-(3,3-dimethylureido)-6-methyl-9,10-didehydroergolin |
|
|
1p-LSD, 1X-XXX |
xxxxxxxxxxx xxxxxxxx 1-propionyl xxxxxxxxx; (6xX,9X)-X,X-xxxxxxx-7-xxxxxx-4-xxxxxxxxx-6,6x,8,9-xxxxxxxxxxxxxxx[4,3-xx]xxxxxxxx-9-xxxxxxxxxx |
||
|
5-XxX-XxXX |
X-[2-(5-xxxxxxx-1X-xxxxx-3-xx)xxxxx]-X-xxxxxxxxxxxx-2-xxxx; 5-methoxy-N-methyl-N-iso-propyl xxxxxxxxx |
||
|
Xxxxxxxxxxxxx |
XXX |
1-[1-(2-xxxxxxxxxxxx)-2-xxxxxxxxxx]xxxxxxxxx |
2-XxX-xxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxxxx |
Xxxxxxx-XxX |
2-xxxxxxx-X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxx |
|
|
2-Xxxxxxxxxxxxxxx |
2-XX |
(2XX)-1-(2-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxxx |
3-XX |
(2XX)-1-(3-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
4-Xxxxxxxxxxxxxxx |
4-XX |
(2XX)-1-(4-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
2-XXXX |
1-(xxxxxxxxxx-2-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
|
3-XXXX |
1-(xxxxxxxxxx-3-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
|
4-XXXX |
1-(xxxxxxxxxx-4-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
|
5-XXXX |
1-(xxxxxxxxxx-5-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
|
6-XXXX |
1-(xxxxxxxxxx-6-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
|
7-XXXX |
1-(xxxxxxxxxx-7-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
|
XXXX |
1-xxxxxx-4-xxxxxxxxxxxxxxx |
||
|
2-Xxxxxx-X,X-xxxxxxxxxxxxxxxx |
2-XXXX |
1-(2-xxxxxxxxxxx)-2-(xxxxxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxx-X,X-xxxxxxxxxxxxxxxx |
3-XXXX |
1-(3-xxxxxxxxxxx)-2-(xxxxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxx-X,X-xxxxxxxxxxxxxxxx |
4-XXXX |
1-(4-xxxxxxxxxxx)-2-(xxxxxxxxxxxxx)xxxxxx-1-xx |
|
|
x-Xxxxxxxxxxxxxxxxxxx |
xXXX |
1-(3-xxxxxxxxxx)xxxxxxxxx |
|
|
Xxxxxxxxxxxx |
XXX |
(2XX)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
XXXX |
5,6-(xxxxxxxxxxxxx)xxxxx-2-xxxx |
||
|
Xxxxxxxxxxxxxxxxx |
XXX, MDEA |
(2RS)-N-ethyl-1-[3,4-(methylendioxy)fenyl]propan-2-amin |
|
|
Ethylon |
bk-MDEA |
2-ethylamino-1-(3,4-methylendioxyfenyl)propan-1-on |
|
|
Methyltenamfetamin |
MDMA |
(2RS)-N-methyl-1-[3,4-(methylendioxy)fenyl]propan-2-amin |
|
|
MDMB-CHMICA |
N-[[1-(cyklohexylmethyl)-1H-indol-3-yl]karbonyl]-3-methyl-valin, methyl xxxxx |
||
|
XXXX-XXXXXXXX |
2-[[1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxx]xxxxx]-3,3-xxxxxxxxxxxxxxxx |
||
|
XXXXX; 3,4-XXXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
||
|
2,3-Xxxxxxxxxxxxxxxxxxxxxxxxx |
2,3-XXXX |
1-(1,3-xxxxxxxxxxx-4-xx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3,4-Xxxxxxxxxxxxxxxxxxxxxxxx |
XXXX |
1-[3,4-(xxxxxxxxxxxxx)xxxxx]-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
XXXX |
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
2-(xxxxxxxxxx)-1-(2-xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
2-(xxxxxxxxxx)-1-(3-xxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxxx |
4-XXX |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxxx |
Xxxxxxxx |
2-(xxxxxxxxxxx)-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
|
|
5-XxX-XXX |
5-xxxxxxx-α-xxxxxxxxxxxxxxx |
||
|
4-Xxxxxxxxxxxx xxxxxxxx |
4-XxX-XX |
X-(4-xxxxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxxx |
|
|
5-XxX-XXXX |
X-[2-(5-xxxxxxx-1X-xxxxx-3-xx)xxxxx]-X-(xxxx-2-xx-1-xx)xxxx-2-xx-1-xxxx |
||
|
3 -Xxxxxxx fencyklidin |
3-MeO-PCP |
1-[1-(3-methoxyfenyl)cyklohexyl]piperidin |
|
|
Meskalin |
3,4,5-trimethoxyfenethylamin |
||
|
Methoxetamin |
MXE |
2-(ethylamino)-2-(3-methoxyfenyl)cyklohexanon |
|
|
Methylaminorex |
(±)-5-fenyl-4-methyl-4,5-dihydrooxazol-2-amin |
||
|
α-Methylfentanyl xxxxxxxxx xxxxxx |
XX; X-X |
2-xxxxxx-X-xxxxx-X-[1-(1-xxxxxxxxxxx-2-xx)xxxxxxxxx-4-xx]xxxxxxxxxx |
|
|
2-Xxxxxx-X-xxxxxxxxxxxxxxxxx |
2-XXXX |
2-(xxxxxxxxxx)-1-(2-xxxxxxxxxxx)-xxxxxx-1-xx |
|
|
3-Xxxxxx-X-xxxxxxxxxxxxxxxxx |
3-XXXX |
2-(xxxxxxxxxx)-1-(3-xxxxxxxxxxx)-xxxxxx-1-xx |
|
|
4-Xxxxxx-X-xxxxxxxxxxxxxxxxx |
4-XXXX |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxxx)-xxxxxx-1-xx |
|
|
Xxxxxxxx |
Xx-XXXX |
2-(xxxxxxxxxxx)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-1-xx |
|
|
2-Xxxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
4-Xxxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
2-(xxxxxxxxxxx)-1-(2-xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
2-(xxxxxxxxxxx)-1-(3-xxxxxxxxxxx)xxxxxx-1-xx |
|
|
Xxxxxxxxxxxxxxxxxxx |
XXXX |
(2XX)-1-[5-xxxxxxx-3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
4-XXX |
1-(4-xxxxxxxxxxx)-2-xxxxxxxxxxx-xxxxxx-1-xx |
||
|
Xxxxxxxxxxxxxxxxxxxxx |
XXX |
X-xxxxxx-1-(xxxxxxx-2-xx)xxxxxx-2-xxxx |
|
|
XX-45 |
1-xxxxxxxxxx-4-(1,2-xxxxxxxxxxxx)xxxxxxxxx |
||
|
2-Xxxxxxxxxxxxxxxxxxx |
2-XXX |
(2XX)-1-[2-(xxxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxxxxxxx |
3-XXX |
(2XX)-1-[3-(xxxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
4-Xxxxxxxxxxxxxxxxxxx |
4-XXX |
(2XX)-1-[4-(xxxxxxxxxxxxxx)xxxxxxxxxxxx-2-xxxx |
|
|
Xxxxxxxx |
4-XXX-xXx; XXX |
(3-xxxxxxx-2-(xxxxxxxxxxx)-1-(x-xxxxx)xxxxxx-1-xx |
|
|
Xxxxxxxxxxxxxxxxx |
Xxxxxxx |
1-(xxxxxxxx-2-xx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
X-2482 |
|
X-xxxxxx-2-xxxxxxxxxx |
X-xxxxxx-2XX |
2,3-xxxxxxx-X-xxxxxx-1X-xxxxx-2-xxxx |
XX-2XX |
|
XX-2201, XXX-2201 |
xxxxxxxx-1-xx-1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
|
XXxxxxxxxx |
X-3217 |
X-(2-xxxxxxxxxx)-2-xxxxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxx |
|
|
x-Xxxxxxxxxxxxxxxxx |
XXX |
3-{-2-[(xxxxxxxxxxxxx)xxxxxx]-1-xxxxxxxxxxxxxxxxx}xxxxx |
|
|
Xxxxxxxxx |
3-xxxxx-6,6,9-xxxxxxxxx-7,8,9,10-xxxxxxxxxx-6X-xxxxx[x]xxxxxxx-1-xx |
||
|
Xxxxxxxxxxx |
XXX |
X-xxxxx-1-xxxxxxxxxxxxxxxxxxx |
|
|
Xxxxxxxxx |
xxxxxxxxx |
1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
x-Xxxxxxxxxxxxxxxxxxx |
xXXX |
1-(4-xxxxxxxxxx)xxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(4-xxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxx |
XXXX |
1-(4-xxxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
Xxxxxxxxxx |
3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx-xxxxxxxxxxxxxxxx |
||
|
Xxxxxxxx |
Xxxxxxxxx |
3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx |
|
|
XX8, α-XXXX |
1-xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxxx-1-xx |
||
|
XX9, α-XXX |
1-xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxx-1-xx |
||
|
α-XXX |
1-xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxxx-1-xx |
||
|
α-XXX |
2-(xxxxxxxxxx-1-xx)-1-(xxxxxxx-2-xx)xxxxxx-1-xx |
||
|
α-Xxxxxxxxxxxxxxxxxxxxxx |
α-XXX |
1-xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxx-1-xx |
|
|
α-Xxxxxxxxxxxxxxxxxxxxxxxxx |
α-XxXX |
1-xxxxx-4-xxxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxxx-1-xx |
|
|
Xxxxxxxxxxxx |
XXX, XXXX |
1-(1-xxxxxxxxxxxxxxx)xxxxxxxxxx |
|
|
Xxxxxxxxxx X |
Xxxxxxxxxx X |
xxxxxx-(2XX,4xX,6xX,7X,9XX,10xXX,10xX)-9-xxxxxxx-2-(xxxxx-3-xx)-6x,10x-xxxxxxxx-4,10-xxxxxxxxxxxxxxxx-1X-xxxxx[x] xxxxxxxxxx-7-xxxxxxxxxx |
|
|
Xxxxxxxxxxxx |
XXX |
1-[1-(2-xxxxxxx)xxxxxxxxxx]xxxxxxxxx |
|
|
1-(3-Xxxxxxxxxxxxxxxxxxx)xxxxxxxxx |
XXXXX |
1-[3-(xxxxxxxxxxxxxx)xxxxx]xxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxxxx |
XXX-X |
X-(1-xxxxxxxxxxxxxxxxxx-4-xx)-X-xxxxxxxxxxxxxxxxxxxx-2-xxxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxxxx |
XXX |
∆6x(10x)-,∆6x(7)-,∆7-,∆8-,∆10-,∆9(11)-xxxxxxxxxxxxxxxxxxxx a xxxxxx xxxxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(3,4,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxx-2 |
XXX-2 |
(2XX)-1-(2,4,5-xxxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
2,4,6-Xxxxxxxxxxxxxxxxxxx |
XXX-6 |
1-(2,4,6-xxxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
XX-144 |
(1-xxxxxx-1X-xxxxx-3-xx)-(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
XXXX-018 |
|
|
X-47700 |
3,4-xxxxxxx-X-[2-(xxxxxxxxxxxxx)xxxxxxxxxx]-X-xxxxxxxxxxxxxx |
||
|
X-49900 |
3,4-xxxxxxx-X-[2-(xxxxxxxxxxxx)xxxxxxxxxx]-X-xxxxxxxxxxxxxx |
||
|
X-51,754 |
2-(3,4-xxxxxxxxxxxx)-X-[2-(xxxxxxxxxxxxx)xxxxxxxxxx]-X-xxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxx |
XXX, VF |
N-fenyl-N-[1-(2-fenylethyl)-4-piperidyl]pentanamid; xxxxxxxx xxxxxxxxxx analog |
|
|
W-15 |
4-chlor-N-(1-fenethylpiperidin-2-yliden)benzensulfonamid |
||
|
W-18 |
4-chlor-N-(1-[2-(4-nitrofenyl)ethyl]-piperidin-2-yliden)benzensulfonamid |
Včetně xxxxxxxxxxxxx xxxxxxxxxxxxxx xxxxx, xx xx výslovné xxxxxxx, xxxxxxxxx x xxxxx xxxxxxx ve xxxxx xxxxxxxxx, xxx xxxx xxxxxxxxxxxxx mohou xxxxxxxxx xxx xxxxxxxxxx xxxxxxxxxx xxxxxxxx x xxxx xxxxxxxxxxxxxx xxxxx xxxxxxxxx x tomto xxxxxxx xx xxxxx xxxxxxxxx, xxx xxxxx xxxxxxxxx.".
Čl. XX
Xxxx xxxxxxxx xxxx oznámeno x xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx (XX) 2015/1535 xx dne 9. xxxx 2015 x xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx x oblasti xxxxxxxxxxx xxxxxxxx x xxxxxxxx xxx služby xxxxxxxxxx společnosti.
Xx. XXX
Xxxx xxxxxxxx xxxxxx účinnosti xxxxxxxxx xxxx xx jeho xxxxxxxxx.
Xxxxxxxx vlády:
Ing. Xxxxx x. x.
Xxxxxxx zdravotnictví:
Mgr. xx Xxx. Vojtěch x. r.
Xxxxxxxxx
Xxxxxx xxxxxxx č. 30/2018 Sb. xxxxx xxxxxxxxx xxxx 8.3.2018.
Znění xxxxxxxxxxxx xxxxxxxx xxxxx xxxxxx xxxxxxxx xxxxxxxx x xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx se xxxx xxxxxx xxxxxxxxx xxxxx xxxxx uvedeného xxxxxxxx xxxxxxxx.